Yamina Dahmoune

Title: Yamina Dahmoune: Innovator in Serotonin Receptor Research

Introduction

Yamina Dahmoune is a notable inventor based in Joinville le Pont, France. He has made significant contributions to the field of serotonin receptor research, particularly through his innovative work on splice variants of the human 5-HT4 serotonin receptor.

Latest Patents

Dahmoune holds a patent for "Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening." This invention involves an isolated polypeptide that constitutes splice variants for the human serotonin receptor. The amino acid sequence is selected among the sequences SEQ ID No. 2 and SEQ ID No. 4 of the 5-HT polypeptide variant, or any polypeptide fragment or biologically active derivative thereof. Additionally, the invention addresses the inverse agonist effect of ML 10375 on 5-HT4(c) and 5-HT4(d) receptors.

Career Highlights

Yamina Dahmoune is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical screening and therapeutic interventions.

Collaborations

Dahmoune has collaborated with esteemed colleagues such as Rodolphe Fischmeister and Michel Langlois, contributing to a rich environment of research and innovation.

Conclusion

Yamina Dahmoune's contributions to serotonin receptor research exemplify the impact of innovative thinking in the medical field. His patent on splice variants of the 5-HT4 receptor highlights the importance of ongoing research in understanding complex biological systems.